| View |
|
DRP-12991-05
|
Mupirocin
|
Bactofer-O
|
20 mg / g (2% w / w)
|
Topical Ointment
|
Antibacterial
|
Opal Laboratories (Pvt.) Limited
|
|
CLIDP Conversion
|
24 September 2024
|
14 November 2027
|
| View |
|
DRP-13048-06
|
Salbutamol (as sulfate) + Ipratropium bromide
|
Lomatubsal
|
2.5 mg/ 500 mcg per 2.5 mL
|
Solution for Inhalation
|
Selective beta-2-adrenoreceptor agonist/Anticholinergic
|
Ahlcon Parenterals (India) Limited
|
India
|
CLIDP Conversion
|
29 September 2024
|
24 November 2027
|
| View |
|
DRP-13059-05
|
Telmisartan + Amlodipine (as besilate)
|
Zenovia
|
40 mg/5 mg
|
Tablet
|
Angiotensin II Receptor Blockers (ARBs) and Calcium Channel Blocker
|
Titan Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
27 September 2024
|
24 November 2027
|
| View |
|
DRP-13089-04
|
Telmisartan + Amlodipine (as besilate)
|
Zenovia
|
80 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blockers (ARBs) and Calcium Channel Blocker
|
Titan Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
28 November 2027
|
| View |
|
DRP-13135-01
|
Ascorbic Acid + Zinc + Cholecalciferol
|
None
|
500mg/30mg/1000IU
|
Capsule
|
Vitamin/Mineral
|
Drugmaker's Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
24 September 2024
|
06 December 2029
|
| View |
|
DRP-13143-01
|
Vildagliptin
|
Retaglip
|
50 mg
|
Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Unison Pharmaceuticals Pvt. Ltd. (Unit I)
|
India
|
CLIDP Conversion
|
28 September 2024
|
07 December 2027
|
| View |
|
DRP-12263-05
|
Ursodeoxycholic Acid
|
Udcapro
|
500 mg
|
Film-Coated Tablet
|
Bile Acid and Derivative
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
15 September 2024
|
06 July 2027
|
| View |
|
DRP-12323-02
|
Telmisartan
|
Telsicare
|
40 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Macter International Trading Inc.
|
Pakistan
|
CLIDP Conversion
|
29 September 2024
|
30 June 2026
|
| View |
|
DRP-13156-02
|
Pioglitazone (as hydrochloride)
|
Retaglitz
|
15 mg
|
Tablet
|
Antidiabetic Agent (Thiazolidinedione)
|
Ind-Swift Limited
|
India
|
CLIDP Conversion
|
24 September 2024
|
12 December 2027
|
| View |
|
DRP-13224-02
|
Paracetamol
|
Parafer
|
10 mg/mL (1g/100 mL)
|
Solution for Injection for I.V. Infusion
|
Analgesic/Antipyretic
|
Osel Ilac San. Ve Tic. A.S.
|
Turkey
|
CLIDP Conversion
|
27 September 2024
|
04 January 2028
|
| View |
|
DRP-13238-08
|
Ursodeoxycholic Acid
|
Ursobest
|
250 mg
|
Capsule
|
Bile Acid and Derivative
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
29 September 2024
|
06 January 2028
|
| View |
|
DRP-1326-07
|
Cefuroxime (as Sodium)
|
Zefur IV
|
750 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Inject Care Parenterals Pvt. Ltd
|
India
|
CLIDP Conversion
|
29 September 2024
|
24 March 2029
|
| View |
|
DRP-13260-01
|
Ticagrelor
|
BriMaed
|
90 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
Medisure Laboratories Pakistan (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
15 September 2024
|
18 January 2028
|
| View |
|
DRP-13319-03
|
Aluminum Hydroxide + Magnesium Hydroxide + Oxetacaine
|
Aluma
|
582 mg/196 mg/20 mg per 10 mL
|
Oral Suspension
|
Antacid
|
Daewon Pharm. Co., Ltd.
|
Korea
|
CLIDP Conversion
|
25 September 2024
|
26 January 2028
|
| View |
|
DRP-13475-08
|
Ipratropium bromide + Salbutamol (as sulfate)
|
Salbubam
|
500 mcg/2.5 mg per 2.5 mL
|
Solution for Inhalation
|
Adrenergic in combination with anticholinergic
|
Legency Remedies Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 September 2024
|
27 February 2028
|
| View |
|
DRP-13514-03
|
Omeprazole (as sodium)
|
Grexole
|
40 mg
|
Lyophilized Powder for Injection (IV)
|
Proton Pump Inhibitor
|
Nitin Lifesciences Ltd. (Unit III)
|
India
|
CLIDP Conversion
|
15 September 2024
|
02 March 2028
|
| View |
|
DRP-13665-03
|
Cefixime (as trihydrate)
|
Techmecef
|
200 mg
|
Dispersible Tablet (Trusil Strawberry Flavor)
|
Antibacterial (Cephalosporin)
|
Innova Captab Ltd.
|
India
|
CLIDP Conversion
|
24 September 2024
|
23 March 2028
|
| View |
|
DRP-13687-08
|
Losartan Potassium
|
Zelosart-50
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 September 2024
|
28 March 2028
|
| View |
|
DRP-13700-01
|
Alfuzosin hydrochloride
|
None
|
10 mg
|
Extended-Release Tablet
|
Alpha-adrenoreceptor Antagonist
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 September 2024
|
29 March 2028
|
| View |
|
DRP-13687-10
|
Losartan Potassium
|
Potazar
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 September 2024
|
28 March 2028
|